Literature DB >> 18779513

Clinical course in migraine: conceptualizing migraine transformation.

Marcelo E Bigal1, Richard B Lipton.   

Abstract

Migraine is currently conceptualized as a chronic disease with episodic manifestations, with attacks that increase in frequency in a subgroup (migraine transformation or progression). Transformation of migraine may be subdivided in three partially overlapping forms, although research in this area is still in infancy, and evidence is sometimes weak. Typically, transformation refers to increases in attack frequency over time leading to chronic migraine; this process is termed clinical transformation. Additionally, in some patients with migraine, physiologic changes in the CNS manifest themselves through alterations in nociceptive thresholds (allodynia) and alterations in pain pathways (physiologic transformation). Finally, in some individuals, definitive brain lesions including stroke and deep white matter lesions emerge (anatomic transformation). Herein we discuss the evidence that migraine may transform and then consider potential mechanisms as well as risk factors. We close with a brief discussion of clinical strategies that arise based on this perspective on migraine.

Entities:  

Mesh:

Year:  2008        PMID: 18779513     DOI: 10.1212/01.wnl.0000325565.63526.d2

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  48 in total

Review 1.  Management of headache in the elderly.

Authors:  Matthew S Robbins; Richard B Lipton
Journal:  Drugs Aging       Date:  2010-05       Impact factor: 3.923

2.  A comparison of the two evidence-based drug therapies for chronic migraine.

Authors:  Frederick R Taylor
Journal:  Curr Pain Headache Rep       Date:  2011-06

Review 3.  Is idiopathic intracranial hypertension without papilledema a risk factor for migraine progression?

Authors:  Roberto De Simone; Angelo Ranieri; Chiara Fiorillo; Leonilda Bilo; Vincenzo Bonavita
Journal:  Neurol Sci       Date:  2010-02-25       Impact factor: 3.307

Review 4.  The pharmacology of nociceptor priming.

Authors:  Ram Kandasamy; Theodore J Price
Journal:  Handb Exp Pharmacol       Date:  2015

Review 5.  Therapeutic antibodies against CGRP or its receptor.

Authors:  Marcelo E Bigal; Sarah Walter; Alan M Rapoport
Journal:  Br J Clin Pharmacol       Date:  2015-06       Impact factor: 4.335

Review 6.  Commonalities between pain and memory mechanisms and their meaning for understanding chronic pain.

Authors:  Theodore J Price; Kufreobong E Inyang
Journal:  Prog Mol Biol Transl Sci       Date:  2015-01-30       Impact factor: 3.622

7.  Sinus venous stenosis-associated idiopathic intracranial hypertension without papilledema as a powerful risk factor for progression and refractoriness of headache.

Authors:  Roberto De Simone; Angelo Ranieri; Silvana Montella; Mario Marchese; Vincenzo Bonavita
Journal:  Curr Pain Headache Rep       Date:  2012-06

Review 8.  Pathophysiology of medication overuse headache: insights and hypotheses from preclinical studies.

Authors:  Ian D Meng; David Dodick; Michael H Ossipov; Frank Porreca
Journal:  Cephalalgia       Date:  2011-03-28       Impact factor: 6.292

Review 9.  How to investigate and treat: migraine in patients with temporomandibular disorders.

Authors:  Daniela A G Gonçalves; Cinara M Camparis; Ana Lucia Franco; Giovana Fernandes; José G Speciali; Marcelo E Bigal
Journal:  Curr Pain Headache Rep       Date:  2012-08

Review 10.  The psychiatric comorbidities of cluster headache.

Authors:  Matthew S Robbins
Journal:  Curr Pain Headache Rep       Date:  2013-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.